Company news

Adagene, Inc. news in 2026

Adagene, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

April 2, 2026

Decks in 2026